-
Product Insights
NewSolute Carrier Family 12 Member 2 – Drugs In Development, 2024
The Solute Carrier Family 12 Member 2 pipeline drugs market research report outlays comprehensive information on the Solute Carrier Family 12 Member 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Genetic Disorders, and Cardiovascular which include indications of Autism Spectrum Disorder (ASD), Epilepsy, Down Syndrome, Fragile X Syndrome, and Ischemic Stroke. It also...
-
Product Insights
NewDiacylglycerol Kinase – Drugs In Development, 2024
The Diacylglycerol Kinase pipeline drugs market research report outlays comprehensive information on the Diacylglycerol Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, and Genetic Disorders which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Unspecified Immunological Disorders, and Fragile X Syndrome. It also reviews key players involved in Diacylglycerol Kinase targeted therapeutics development...
-
Product Insights
NewMethyl CpG Binding Protein 2 – Drugs In Development, 2024
The Methyl CpG Binding Protein 2 pipeline drugs market research report outlays comprehensive information on the Methyl CpG Binding Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, and Genetic Disorders which include indications of Rett Syndrome, Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy), and X Chromosome Disorders. It also reviews key players...
-
Product Insights
NewPhosphodiesterase 10 – Drugs In Development, 2024
The Phosphodiesterase 10 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 10 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Genetic Disorders, and Gastrointestinal which include indications of Schizophrenia, Tourette Syndrome, Lung Cancer, Solid Tumor, Fragile X Syndrome, Prader-Willi Syndrome (PWS), and Ulcerative Colitis. It also reviews key players involved...
-
Product Insights
NewPurinergic Receptor P2X – Drugs In Development, 2024
The Purinergic Receptor P2X pipeline drugs market research report outlays comprehensive information on the Purinergic Receptor P2X targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Dermatology, and Genetic Disorders which include indications of Pain, Neuropathic Pain (Neuralgia), Chronic Cough, Cough, Dermatology, Hidradenitis Suppurativa, Fragile X Syndrome, and Charcot-Marie-Tooth Disease Type I A. It...
-
Product Insights
NewGamma-Aminobutyric Acid Receptor Subunit Alpha 2 – Drugs In Development, 2024
The Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Genetic Disorders, and Cardiovascular which include indications of Epilepsy, Depression, Fragile X Syndrome, and Acute Ischemic Stroke. It also reviews key players involved...
-
Product Insights
NewGamma-Aminobutyric Acid Receptor Subunit Alpha 3 – Drugs In Development, 2024
The Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Genito Urinary System, and Genetic Disorders which include indications of Epilepsy, Neuropathic Pain (Neuralgia), Primary Hyperoxaluria, Renal Insufficiency, and Fragile X Syndrome. It...
-
Product Insights
NewcAMP and cAMP Inhibited cGMP 3′,5′ Cyclic Phosphodiesterase 10A – Drugs In Development, 2024
The cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A pipeline drugs market research report outlays comprehensive information on the cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, and Genetic Disorders which include indications of Schizophrenia, Tourette Syndrome, Lung Cancer, and Fragile X Syndrome....
-
Product Insights
NewSodium Dependent Dopamine Transporter – Drugs In Development, 2024
The Sodium Dependent Dopamine Transporter pipeline drugs market research report outlays comprehensive information on the Sodium Dependent Dopamine Transporter targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Women's Health, Metabolic Disorders, and Genetic Disorders which include indications of Attention Deficit Hyperactivity Disorder (ADHD), Post-Traumatic Stress Disorder (PTSD), Female Sexual Dysfunction, Female Hypoactive Sexual Desire...
-
Product Insights
NewAdenosine Receptor A2a – Drugs In Development, 2024
The Adenosine Receptor A2a pipeline drugs market research report outlays comprehensive information on the Adenosine Receptor A2a targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Genetic Disorders, and Infectious Disease which include indications of Solid Tumor, Unspecified Cancer, Parkinson's Disease, Alzheimer's Disease, Fragile X Syndrome, Spinocerebellar Ataxia (SCA), Sepsis, and Clostridioides difficile Infections...